Please check your internet connection and try again.
# Ecospirin Enteric-Coated (Aspirin)
## Overview
Ecospirin Enteric-Coated is a brand name for aspirin, a nonsteroidal anti-inflammatory drug (NSAID) that possesses analgesic, anti-inflammatory, and antipyretic properties. The enteric coating is designed to delay the release of aspirin until it reaches the small intestine, which may reduce gastrointestinal irritation.
## Primary Indications
* Pain relief (mild to moderate)
* Fever reduction
* Inflammation reduction
* Prevention of cardiovascular events (e.g., myocardial infarction, stroke) in specific patient populations (e.g., those with established cardiovascular disease, certain risk factors).
## Adult Dosing
* **Analgesic/Antipyretic:** 325 mg to 1000 mg every 4 to 6 hours as needed. Maximum daily dose is generally 4000 mg, but lower doses are often preferred to minimize toxicity.
* **Anti-inflammatory:** 2000 mg to 5400 mg per day, divided into 4 to 6 doses.
* **Cardiovascular Prevention:** Typically 75 mg to 162 mg once daily. The specific dose and indication should be guided by current clinical guidelines.
*Note: Dosing for cardiovascular prevention is highly individualized and should follow established guidelines.*
## Pediatric Dosing
Aspirin is generally **not recommended** for children and teenagers due to the risk of Reye's syndrome, a rare but serious condition that can cause liver and brain damage, especially when given for viral illnesses. If aspirin is deemed absolutely necessary by a healthcare professional, specific pediatric dosing guidelines should be followed:
* **Analgesic/Antipyretic:** 10 mg/kg to 15 mg/kg per dose orally every 4 to 6 hours. Maximum dose: 650 mg per dose or 4000 mg per day.
*Note: Due to the risk of Reye's syndrome, acetaminophen or ibuprofen are preferred for fever and pain in pediatric patients.*
## Dose Adjustments
* **Renal Impairment:** Use with caution. Higher doses may accumulate. Consider dose reduction in severe renal impairment.
* **Hepatic Impairment:** Use with caution. Monitor liver function.
* **Elderly:** Increased risk of adverse effects, particularly GI bleeding. Lower doses may be preferred.
## Contraindications
* Known hypersensitivity to aspirin, salicylates, NSAIDs, or any component of the formulation.
* Active peptic ulceration or gastrointestinal bleeding.
* History of gastrointestinal bleeding or perforation related to prior NSAID therapy.
* Children and teenagers with viral infections (e.g., influenza, chickenpox) due to the risk of Reye's syndrome.
* Severe hepatic or renal impairment.
* Certain bleeding disorders (e.g., hemophilia).
* Third trimester of pregnancy.
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, vomiting, abdominal pain, gastritis, peptic ulceration, GI bleeding, perforation.
* **Hematologic:** Increased bleeding time, bruising, epistaxis, prolonged bleeding from cuts.
* **Auditory:** Tinnitus, hearing loss (especially at higher doses).
* **Allergic:** Urticaria, rash, angioedema, bronchospasm, anaphylaxis.
* **Renal:** Renal dysfunction, interstitial nephritis.
* **Hepatic:** Hepatotoxicity (rare).
* **Other:** Dizziness, headache, confusion, hyperventilation.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, direct oral anticoagulants):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 Inhibitors:** Increased risk of GI toxicity and bleeding.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Alcohol:** Increased risk of GI bleeding.
* **Methotrexate:** May increase methotrexate toxicity.
* **Uricosuric agents (e.g., probenecid):** May decrease the efficacy of uricosuric agents.
* **Antihypertensives:** May decrease the efficacy of some antihypertensives (e.g., ACE inhibitors, diuretics).
* **Valproic Acid:** May increase serum levels of valproic acid.
* **Selective Serotonin Reuptake Inhibitors (SSRIs):** Increased risk of bleeding.
## Monitoring
* Signs and symptoms of GI bleeding (e.g., melena, hematemesis, abdominal pain).
* Signs of bruising or excessive bleeding.
* Renal function (serum creatinine, BUN), especially in patients with pre-existing renal disease or those on chronic therapy.
* Liver function tests (LFTs), especially with long-term or high-dose use.
* Tinnitus or hearing changes may indicate toxicity.
## Clinical Pearls
* The enteric coating should not be crushed or chewed, as this can destroy the coating and increase the risk of gastric irritation.
* For patients requiring long-term, low-dose aspirin for cardiovascular prophylaxis, the 75-162 mg daily dose is standard.
* Always consider the patient's risk factors for GI bleeding and cardiovascular events when initiating or continuing aspirin therapy.
* In cases of suspected aspirin toxicity, assess for salicylism (tinnitus, dizziness, nausea) and acid-base disturbances.
***
*Disclaimer: This information is intended for healthcare professionals and does not substitute for professional medical advice. Always consult the most current prescribing information and relevant clinical guidelines before making any treatment decisions.*
